Factors Associated with Severity of Acute Kidney Injury and Adverse Outcomes in Critically Ill Patients with COVID-19Christopher El Mouhayyar, Vaidyanathapuram S. Balakrishnan, Jonathan Dewald et al.|The Nephron journals/Nephron journals|2022Cited by 13
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort studyChristopher D. Barrett, Michael B. Yaffe, Hunter B. Moore et al.|Research and Practice in Thrombosis and Haemostasis|2022Cited by 9
Real-World Outcomes Following Asthma Treatment Escalation From Medium-Dose ICS to high-Dose ICS or BiologicsNjira Lugogo, Aakash Bipin Gandhi, Rohit Katial et al.|Journal of Allergy and Clinical Immunology|2026Cited by 0